Pharma producers want bi-annual update of compensate drugs’ list, clawback tax revision


The Romanian Association of International Medicine Manufacturers (APRIM), the Association for Generic Medicine Producers (APMGR), and the Local American Working Group Association (LAWG), have presented a series of measures aimed at improving the Romanian health system, which have already been proposed to the Romanian Government, to the International Monetary Fund (IMF), European Commission (EC), and World Bank (WB) representatives.
According to a press release, the proposals drafted for this year focus on revising the list of compensated drugs, introducing new molecules in the first quarter, revising the clawback tax by introducing the differential calculus method based on dividing drugs into two groups, introducing price and volume agreements for new compensated drugs with additional budget, eliminating distributors and pharmacies’ surplus from the clawback tax paid by manufacturers and finding measures to achieve a fair distribution of the fiscal burden along the drug distribution chain, updating the list of compensated drugs with new molecules and changing the price setting policy to prevent patients’ lack of access to drugs. Companies also want the law regarding the reference budget for the clawback tax to be upheld and the reference budget to be in accordance with the current budget allotted to drugs.
On the long term, pharmaceutical manufacturers want a progressive increase in public health financing in order to reach the average European financing level for the 2014 – 2020 period, an annual adjustment in the reference budget relative to the net consumption of drugs in the previous year, in addition to the clawback contribution being considered only a provisional measure that will be eliminated once the economy stabilizes. They also request that health cards be implemented, as well as measures for improving efficiency in public expenditures and fighting fraud.
“The Romanian health system is one of the most poorly financed systems in the European Union, and we need to work together with the decision-making bodies in order to change this reality. The pharmaceutical industry has been a true partner of the authorities so far by actively contributing to maintain a constant level of the current health system. Between 2012 and 2013 alone, two out of ten Romanian patients have been treated exclusively thanks to contributions made by the pharmaceuticals industry through the clawback tax,” Calin Galaseanu, President of ARPIM, stated.
On the other hand, President Traian Basescu yesterday, at 6 pm, received the joint delegation of the International Monetary Fund (IMF), the European Commission (EC) and the World Bank (WB) at the Cotroceni Palace, informs the Presidential Administration. Traian Basescu had one more meeting with the delegation of the IMF, the EC and the WB on January 23, an occasion on which the President reiterated the fact that he did not support the introduction of the fuel excise and said he would not block the decisions these institutions made with Romania’s Government, but they should not ask him to sign what they were negotiating for.

Leave a Reply